NHS GP highlights ‘massively underdiagnosed’ condition that causes breathlessness and pain

NHS GP Raises Awareness of Underdiagnosed Condition Causing Breathlessness and Pain

An NHS General Practitioner has drawn attention to a condition that is significantly underdiagnosed and can manifest with symptoms like breathlessness, itching, and pain. Dr. Ahmed, known as @Dra_says on social media, discussed Mast Cell Activation Syndrome (MCAS) in a recent TikTok video. According to NHS research, MCAS can trigger severe allergic symptoms varying from intense itching and swelling to potentially life-threatening anaphylactic reactions. In cases where a severe allergic reaction is suspected, such as struggling to breathe, immediate dialing of 999 is crucial.

Diagnosing MCAS can pose challenges, as noted by Dr. Ahmed, who stresses the condition’s underdiagnosis. Mast cells, spread throughout the body in areas like the skin, gut, and respiratory system, play a key role in the immune system by detecting allergens and releasing histamine in response. However, in MCAS, these cells can be triggered by non-allergenic factors like food, temperature changes, or stress. The diverse symptoms of MCAS make diagnosis difficult, with skin writing being one notable symptom described by the doctor – a reaction causing raised red marks from minor skin contact.

Treatment for MCAS involves identifying triggers and using H1 and H2 receptor antagonists to manage symptoms. While there is no specific cure, successful treatment can yield transformative results, as illustrated by a patient who experienced alleviation of fibromyalgia symptoms upon receiving MCAS treatment. It is important to consult a doctor if experiencing persistent symptoms, even though not all symptoms indicate MCAS.

The UK Mastocytosis Support Group highlights the lack of recognition for MCAS within the UK medical system compared to international standards. While the condition has gained recognition in the US, it is still not recognised globally. Dr. Ahmed emphasises the importance of history and symptom response in diagnosing MCAS. Despite the challenges, early identification and management of MCAS can significantly improve patients’ quality of life and overall health.

Insights and Summary:
Dr. Ahmed’s advocacy for raising awareness of Mast Cell Activation Syndrome sheds light on a condition that often goes undiagnosed, leading to prolonged suffering for individuals experiencing its diverse symptoms. By educating the public about the potential triggers, symptoms, and treatment options for MCAS, he is empowering individuals to seek timely medical intervention and support. This proactive approach not only aids in early diagnosis but also highlights the importance of considering rare conditions in the differential diagnosis, ensuring comprehensive healthcare delivery.